Healthcare | August 03, 2021
Nureca Ltd PAT at Rs 36.19 crore in Q1FY22
Nureca Ltd has reported financial results for the period ended June 30, 2021.
Nureca Ltd has reported financial results for the period ended June 30, 2021.
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
India business is growing as per projections; whereas US business will bounce back soon.
Turnover of API division of ISLL stood at Rs 856.58 crore
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
Price band in the range of Rs 933 to Rs 954
The company posted net profit of Rs.2.43 crores for the period ended June 30, 2020.
It posted net profit of Rs.147.76 crores for the period ended June 30, 2020.
The company posted net profit of Rs.89.20 crores for the period ended June 30, 2020.
Subscribe To Our Newsletter & Stay Updated
